Market Value3,203,503,000
Total Holdings70
File Date2022-05-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
OSH / Oak Street Health Inc
IMGN / ImmunoGen, Inc.
TNDM / Tandem Diabetes Care, Inc.
RPTX / Repare Therapeutics Inc.
NVTA / Invitae Corporation
TCRR / Tcr2 Therapeutics Inc
ALXO / ALX Oncology Holdings Inc.
BVS / Bioventus Inc.
GRTSQ / Gritstone bio, Inc.
HOOK / HOOKIPA Pharma Inc.
AKRO / Akero Therapeutics, Inc.
FATE / Fate Therapeutics, Inc.
ADCT / ADC Therapeutics SA
BCEL / Atreca, Inc.
EPZM / Epizyme Inc
CABA / Cabaletta Bio, Inc.
SGEN / Seagen Inc
MDVL / MedAvail Holdings, Inc.
NLTX / Neoleukin Therapeutics, Inc.
UNH / UnitedHealth Group Incorporated
RCEL / AVITA Medical, Inc.
STTK / Shattuck Labs, Inc.
NVRO / Nevro Corp.
IMTX / Immatics N.V.
STXS / Stereotaxis, Inc.
NGM / NGM Biopharmaceuticals, Inc.
ZGNX / Zogenix Inc
SKIN / The Beauty Health Company
/ ONCOLOGY INSTITUTE INC/THE
ARGX / argenx SE - Depositary Receipt (Common Stock)
LVTX / LAVA Therapeutics N.V.
KYMR / Kymera Therapeutics, Inc.
XERS / Xeris Biopharma Holdings, Inc.
NUVB / Nuvation Bio Inc.
ICUI / ICU Medical, Inc.
GMXAY / Genmab A/S
DCPH / Deciphera Pharmaceuticals, Inc.
CTSO / Cytosorbents Corporation
ONEM / 1life Healthcare Inc
PRTA / Prothena Corporation plc
ISEE / IVERIC bio Inc
ZYME / Zymeworks Inc.
ELV / Elevance Health, Inc.
CNC / Centene Corporation
TKNO / Alpha Teknova, Inc.
RAPT / RAPT Therapeutics, Inc.
TRDA / Entrada Therapeutics, Inc.
STVN / Stevanato Group S.p.A.
SLGC / Standard BioTools Inc.
JAZZ / Jazz Pharmaceuticals plc
IVVD / Invivyd, Inc.
AYLA / Ayala Pharmaceuticals Inc
NRIX / Nurix Therapeutics, Inc.
SRRK / Scholar Rock Holding Corporation
PLRX / Pliant Therapeutics, Inc.
VERV / Verve Therapeutics, Inc.
ALLK / Allakos Inc.
IGMS / IGM Biosciences, Inc.
LSAQ / LifeSci Acquisition II Corp
SONX / Sonendo, Inc.
BEAM / Beam Therapeutics Inc.
CLDX / Celldex Therapeutics, Inc.
ATRA / Atara Biotherapeutics, Inc.
LIVN / LivaNova PLC
REPL / Replimune Group, Inc.
KRYS / Krystal Biotech, Inc.
RGNX / REGENXBIO Inc.
ALVR / AlloVir, Inc.
ABSI / Absci Corporation
FOLD / Amicus Therapeutics, Inc.
ACHL / Achilles Therapeutics plc - Depositary Receipt (Common Stock)
ANNX / Annexon, Inc.
STOK / Stoke Therapeutics, Inc.
AUGX / Augmedix, Inc.